title: Quercetin Partially Preserves Development of Osteoblast Phenotype in Fetal Rat Calvaria Cells in an Oxidative Stress Environment.
abstract: Studies are needed to improve understanding of the osteoblast antioxidant response, and the balance between oxidative homeostasis and osteoblast differentiation. The flavonol quercetin aglycone (QRC) up-regulates the osteoblast antioxidant response in vitro without suppressing osteoblast phenotype, suggesting that QRC may preserve osteoblast phenotypic development in cells subsequently exposed to oxidative stress, which suppresses osteoblast differentiation. The aims of this study were to assess the extent that QRC pretreatment preserved development of the osteoblast phenotype in cells subsequently cultured with hydrogen peroxide, an oxidative stressor, and to characterize alterations in the osteoblast antioxidant response and in key antioxidant signaling pathways. We hypothesized that pretreatment with QRC would preserve phenotypic development after hydrogen peroxide treatment, suppress the hydrogen peroxide-induced antioxidant response, and that the antioxidant response would involve alterations in Nrf2 and ERK1/2 signaling. Results showed that treating fetal rat calvarial osteoblasts for 4 days (D5-9) with 300 μM hydrogen peroxide resulted in fewer alkaline phosphatase-positive cells and mineralized nodules, altered cell morphology, and significantly lower osteoblast phenotypic gene expression (P < 0.05). This suppression was partially blocked when cells were pretreated 12 h with 20 μM QRC. Hydrogen peroxide also produced sustained up-regulation of heme oxygenase-1 (HO-1) and γ-glutamate cysteine ligase catalytic subunit (GCLC), which was partially blocked in hydrogen peroxide-treated cells that first received QRC pretreatment. The alterations in the antioxidant stress response coincided with alterations in phosphorylated ERK1/2, but not Nrf2. These results suggest that QRC suppresses hydrogen peroxide-induced activation of the antioxidant response, and partially preserves osteoblast phenotypic development. J. Cell. Physiol. 231: 2779-2788, 2016. © 2016 Wiley Periodicals, Inc.
authors.affiliation: Department of Nutrition, University of North Carolina at Greensboro, Greensboro, North Carolina.
authors.forename: Jonathan G
authors.initials: JG
authors.lastname: Messer
authors.affiliation: Department of Nutrition, University of North Carolina at Greensboro, Greensboro, North Carolina.
authors.forename: Stephanie
authors.initials: S
authors.lastname: La
authors.affiliation: Department of Nutrition, University of North Carolina at Greensboro, Greensboro, North Carolina.
authors.forename: Robin G
authors.initials: RG
authors.lastname: Hopkins
authors.affiliation: Department of Nutrition, University of North Carolina at Greensboro, Greensboro, North Carolina.
authors.forename: Deborah E
authors.initials: DE
authors.lastname: Kipp
mesh_terms: D000469:Alkaline Phosphatase / Q000378:metabolism; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D048430:Cell Shape / Q000187:drug effects; D005260:Female; D005333:Fetus / Q000473:pathology*; D006861:Hydrogen Peroxide / Q000633:toxicity; D010006:Osteoblasts / Q000187:drug effects / Q000378:metabolism / Q000473:pathology*; D018384:Oxidative Stress / Q000187:drug effects*; D010641:Phenotype; D011794:Quercetin / Q000494:pharmacology*; D017207:Rats, Sprague-Dawley; D012886:Skull / Q000473:pathology*; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D000975:Antioxidants; D011794:Quercetin; D006861:Hydrogen Peroxide; D000469:Alkaline Phosphatase